N-Acetylcysteine amide (abbrev. NACA AD4 and also known as acetylcysteinamide) is a recently synthesised amide derivative of N-acetylcysteine that appears to have better blood-brain barrier permeability and bioavailability and a similar antioxidant capability.
This page contains content from the copyrighted Wikipedia article "Acetylcysteinamide"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
